2,700,000 Shares Endologix, Inc. Common Stock PURCHASE AGREEMENTPurchase Agreement • May 31st, 2012 • Endologix Inc /De/ • Surgical & medical instruments & apparatus • New York
Endologix, Inc., a Delaware corporation (the “Company”) proposes to sell to Piper Jaffray & Co. (the “Underwriter”) an aggregate of 2,700,000 shares (the “Firm Shares”) of Common Stock, $0.001 par value per share (the “Common Stock”), of the Company. The Company has also granted to the Underwriter an option to purchase up to 405,000 additional shares of Common Stock on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Purchase Agreement are herein collectively called the “Securities.”
